S
Sanofi ADR (SNY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
$48.39
+0.02 (+0.04%)
Market Cap: $116.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sanofi ADR (SNY) Valuation Multiples
Sanofi ADR (SNY) trades at 2.0x sales and 1.4x book value. Its P/S of 2.0x is below its 5-year median of 2.6x.
Current Multiples
SNY reports in EUR, so earnings multiples appear here only when its per-share earnings can be confirmed.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 2.0x |
| Price to book | 1.4x |
| EV/EBITDA | 7.3x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/S is 25.9% below 2.7x and its P/B is 12.5% below 1.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.0x | 2.6x | 2.7x |
| P/B | 1.4x | 1.5x | 1.6x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 2.2x in 2025 to 3.0x in 2019. 2025 was the lowest of those years.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $48.46 | 2.2x | 1.4x |
| 2024 | $48.23 | 2.6x | 1.5x |
| 2023 | $49.73 | 2.5x | 1.5x |
| 2022 | $48.43 | 2.6x | 1.5x |
| 2021 | $50.10 | 2.8x | 1.6x |
| 2020 | $48.59 | 2.8x | 1.6x |
| 2019 | $50.20 | 3.0x | 1.9x |
| 2018 | $43.41 | 2.6x | 1.6x |
| 2017 | $43.00 | 2.6x | 1.5x |
| 2016 | $40.44 | 2.7x | 1.7x |
P/E history is shown only for companies that report in US dollars.
Frequently Asked Questions About SNY
What is SNY's price to sales ratio?
Sanofi ADR has a price to sales ratio of 2.0x.
SNY pages: Overview, Dividends, Financials, Valuation, Competitors, Government Contracts